A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 303,284 shares of HALO stock, worth $17.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
303,284
Previous 277,072 9.46%
Holding current value
$17.7 Million
Previous $11.3 Million 40.88%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$37.81 - $52.4 $991,075 - $1.37 Million
26,212 Added 9.46%
303,284 $15.9 Million
Q1 2024

May 09, 2024

BUY
$33.68 - $41.95 $5,725 - $7,131
170 Added 0.06%
277,072 $11.3 Million
Q4 2023

Mar 05, 2024

BUY
$33.32 - $42.1 $2,665 - $3,368
80 Added 0.03%
276,902 $10.2 Million
Q4 2023

Feb 06, 2024

BUY
$33.32 - $42.1 $52,878 - $66,812
1,587 Added 0.58%
276,822 $10.2 Million
Q3 2023

Nov 13, 2023

SELL
$36.46 - $44.03 $5.62 Million - $6.78 Million
-154,084 Reduced 35.89%
275,235 $10.5 Million
Q2 2023

Dec 12, 2023

BUY
$30.28 - $38.74 $4.67 Million - $5.97 Million
154,084 Added 55.98%
429,319 $15.5 Million
Q2 2023

Aug 08, 2023

SELL
$30.28 - $38.74 $207,206 - $265,097
-6,843 Reduced 1.57%
429,319 $15.5 Million
Q1 2023

Dec 12, 2023

BUY
$32.86 - $55.7 $5.16 Million - $8.75 Million
157,074 Added 57.07%
432,309 $16.5 Million
Q1 2023

May 01, 2023

BUY
$32.86 - $55.7 $8,050 - $13,646
245 Added 0.06%
436,162 $16.7 Million
Q4 2022

Feb 03, 2023

SELL
$40.06 - $59.44 $10.1 Million - $15 Million
-253,083 Reduced 36.73%
435,917 $24.8 Million
Q3 2022

Nov 08, 2022

SELL
$38.53 - $51.78 $12.6 Million - $16.9 Million
-326,289 Reduced 32.14%
689,000 $27.2 Million
Q2 2022

Aug 09, 2022

BUY
$37.35 - $48.3 $2.76 Million - $3.56 Million
73,775 Added 7.84%
1,015,289 $44.7 Million
Q1 2022

May 05, 2022

SELL
$31.97 - $41.06 $38,875 - $49,928
-1,216 Reduced 0.13%
941,514 $37.5 Million
Q4 2021

Feb 02, 2022

SELL
$31.82 - $40.75 $2 Million - $2.56 Million
-62,708 Reduced 6.24%
942,730 $37.9 Million
Q3 2021

Oct 26, 2021

BUY
$38.47 - $46.42 $3.14 Million - $3.79 Million
81,724 Added 8.85%
1,005,438 $40.9 Million
Q2 2021

Jul 27, 2021

BUY
$38.84 - $51.31 $995,741 - $1.32 Million
25,637 Added 2.85%
923,714 $41.9 Million
Q1 2021

Apr 27, 2021

SELL
$39.51 - $51.45 $499,327 - $650,225
-12,638 Reduced 1.39%
898,077 $37.4 Million
Q4 2020

Jan 29, 2021

SELL
$25.81 - $43.62 $1.12 Million - $1.89 Million
-43,442 Reduced 4.55%
910,715 $38.9 Million
Q3 2020

Nov 10, 2020

SELL
$25.74 - $29.63 $2.64 Million - $3.04 Million
-102,514 Reduced 9.7%
954,157 $25.1 Million
Q2 2020

Aug 07, 2020

SELL
$16.25 - $26.81 $617,500 - $1.02 Million
-38,000 Reduced 3.47%
1,056,671 $28.3 Million
Q1 2020

Apr 28, 2020

SELL
$13.9 - $21.83 $1.22 Million - $1.92 Million
-87,992 Reduced 7.44%
1,094,671 $19.7 Million
Q4 2019

Feb 12, 2020

BUY
$14.93 - $19.53 $190,312 - $248,948
12,747 Added 1.09%
1,182,663 $21 Million
Q3 2019

Oct 29, 2019

BUY
$15.2 - $17.69 $102,691 - $119,513
6,756 Added 0.58%
1,169,916 $18.1 Million
Q2 2019

Jul 30, 2019

BUY
$14.75 - $17.26 $3.27 Million - $3.82 Million
221,470 Added 23.52%
1,163,160 $20 Million
Q1 2019

Apr 22, 2019

BUY
$13.94 - $17.58 $1.06 Million - $1.33 Million
75,771 Added 8.75%
941,690 $15.2 Million
Q4 2018

Jan 25, 2019

BUY
$13.33 - $18.66 $5.58 Million - $7.81 Million
418,581 Added 93.57%
865,919 $12.7 Million
Q3 2018

Oct 24, 2018

SELL
$16.68 - $18.41 $105,317 - $116,240
-6,314 Reduced 1.39%
447,338 $8.13 Million
Q2 2018

Jul 09, 2018

SELL
$16.87 - $20.3 $748,386 - $900,548
-44,362 Reduced 8.91%
453,652 $7.65 Million
Q1 2018

May 11, 2018

SELL
$17.06 - $21.2 $11.1 Million - $13.8 Million
-651,928 Reduced 56.69%
498,014 $9.76 Million
Q1 2018

Apr 19, 2018

BUY
$17.06 - $21.2 $10.1 Million - $12.5 Million
589,569 Added 105.21%
1,149,942 $22.5 Million
Q4 2017

Jan 24, 2018

SELL
$16.75 - $20.8 $382,704 - $475,238
-22,848 Reduced 3.92%
560,373 $11.4 Million
Q3 2017

Oct 17, 2017

BUY
$11.76 - $17.4 $6.86 Million - $10.1 Million
583,221
583,221 $10.1 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8.14B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.